DE2319097C3 - Verfahren zur Bestimmung der enzymatischen Aktivität von Mono-Amin-Oxydase - Google Patents
Verfahren zur Bestimmung der enzymatischen Aktivität von Mono-Amin-OxydaseInfo
- Publication number
- DE2319097C3 DE2319097C3 DE2319097A DE2319097A DE2319097C3 DE 2319097 C3 DE2319097 C3 DE 2319097C3 DE 2319097 A DE2319097 A DE 2319097A DE 2319097 A DE2319097 A DE 2319097A DE 2319097 C3 DE2319097 C3 DE 2319097C3
- Authority
- DE
- Germany
- Prior art keywords
- benzaldehyde
- mao
- azo
- solution
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims description 44
- 102000010909 Monoamine Oxidase Human genes 0.000 title claims description 39
- 108010062431 Monoamine oxidase Proteins 0.000 title claims description 39
- 230000002255 enzymatic effect Effects 0.000 title claims description 18
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 38
- 239000000758 substrate Substances 0.000 claims description 36
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 30
- -1 benzylamine compound Chemical class 0.000 claims description 22
- 238000010521 absorption reaction Methods 0.000 claims description 21
- 239000011541 reaction mixture Substances 0.000 claims description 15
- WGQKYBSKWIADBV-UHFFFAOYSA-N aminomethyl benzene Natural products NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 claims description 13
- 230000003287 optical effect Effects 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 38
- 239000000243 solution Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 210000002966 serum Anatomy 0.000 description 21
- 238000002835 absorbance Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 239000002904 solvent Substances 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 229950011260 betanaphthol Drugs 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 8
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000006911 enzymatic reaction Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 125000000753 cycloalkyl group Chemical group 0.000 description 4
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 4
- 238000006193 diazotization reaction Methods 0.000 description 4
- 125000001624 naphthyl group Chemical group 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- RHUCPPAVIRXPDM-UHFFFAOYSA-N 2-methyl-4H-pyrazol-3-one hydrochloride Chemical compound Cl.CN1N=CCC1=O RHUCPPAVIRXPDM-UHFFFAOYSA-N 0.000 description 3
- GMYWFOGAJAQFHN-UHFFFAOYSA-N 4-(aminomethyl)aniline;dihydrochloride Chemical compound Cl.Cl.NCC1=CC=C(N)C=C1 GMYWFOGAJAQFHN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 235000010288 sodium nitrite Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 2
- FFQXZGSJZAYPPG-UHFFFAOYSA-N 4-[[4-(aminomethyl)phenyl]diazenyl]-5-methyl-2-phenyl-4H-pyrazol-3-one Chemical compound NCC1=CC=C(C=C1)N=NC1C(=NN(C1=O)C1=CC=CC=C1)C FFQXZGSJZAYPPG-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- NHOWLEZFTHYCTP-UHFFFAOYSA-N benzylhydrazine Chemical compound NNCC1=CC=CC=C1 NHOWLEZFTHYCTP-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N beta-hydroxynaphthyl Natural products C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 150000008049 diazo compounds Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 2
- 229940011051 isopropyl acetate Drugs 0.000 description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000013188 needle biopsy Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical group O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 125000005504 styryl group Chemical group 0.000 description 2
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- QXFZDORWDUYECA-UHFFFAOYSA-N 1-[[4-(aminomethyl)phenyl]diazenyl]naphthalen-2-ol Chemical compound C1=CC(CN)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 QXFZDORWDUYECA-UHFFFAOYSA-N 0.000 description 1
- KEHFMHSZIGDXOQ-UHFFFAOYSA-N 1-[[4-(aminomethyl)phenyl]diazenyl]naphthalen-2-ol hydrochloride Chemical compound Cl.C1=CC(CN)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 KEHFMHSZIGDXOQ-UHFFFAOYSA-N 0.000 description 1
- KGLPWQKSKUVKMJ-UHFFFAOYSA-N 2,3-dihydrophthalazine-1,4-dione Chemical compound C1=CC=C2C(=O)NNC(=O)C2=C1 KGLPWQKSKUVKMJ-UHFFFAOYSA-N 0.000 description 1
- FOBVDBSEYFIUCA-UHFFFAOYSA-N 2-[(3-aminophenyl)methyl]isoindole-1,3-dione Chemical compound NC1=CC=CC(CN2C(C3=CC=CC=C3C2=O)=O)=C1 FOBVDBSEYFIUCA-UHFFFAOYSA-N 0.000 description 1
- JUENLTGHHRJGCC-UHFFFAOYSA-N 2-[[4-(aminomethyl)phenyl]diazenyl]-5-(dimethylamino)phenol hydrochloride Chemical compound Cl.NCC1=CC=C(C=C1)N=NC1=C(C=C(N(C)C)C=C1)O JUENLTGHHRJGCC-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- NDUMKMMEGBGQFT-UHFFFAOYSA-N 4-[[3-(aminomethyl)phenyl]diazenyl]-n,n-dimethylaniline;dihydrochloride Chemical compound Cl.Cl.C1=CC(N(C)C)=CC=C1N=NC1=CC=CC(CN)=C1 NDUMKMMEGBGQFT-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- YDVYKVZYABCGQH-UHFFFAOYSA-N Cl.NCC1=CC=C(C=C1)N=NC1=CC(=CC=C1O)C Chemical compound Cl.NCC1=CC=C(C=C1)N=NC1=CC(=CC=C1O)C YDVYKVZYABCGQH-UHFFFAOYSA-N 0.000 description 1
- NNEZMHLLUVSVDZ-UHFFFAOYSA-N Cl.NCC=1C=C(C=CC1)N=NC1=C(C=CC2=CC=CC=C12)O Chemical group Cl.NCC=1C=C(C=CC1)N=NC1=C(C=CC2=CC=CC=C12)O NNEZMHLLUVSVDZ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- MNAQQHWMIALRPQ-UHFFFAOYSA-N n,n-dimethylaniline;dihydrochloride Chemical compound Cl.Cl.CN(C)C1=CC=CC=C1 MNAQQHWMIALRPQ-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000007833 oxidative deamination reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3866872A JPS5829080B2 (ja) | 1972-04-19 | 1972-04-19 | モノアミンオキシダ−ゼ ノ ソクテイホウ |
| JP2352173A JPS5551559B2 (cg-RX-API-DMAC10.html) | 1973-02-27 | 1973-02-27 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DE2319097A1 DE2319097A1 (de) | 1973-11-08 |
| DE2319097B2 DE2319097B2 (de) | 1975-02-27 |
| DE2319097C3 true DE2319097C3 (de) | 1975-10-09 |
Family
ID=26360889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2319097A Expired DE2319097C3 (de) | 1972-04-19 | 1973-04-16 | Verfahren zur Bestimmung der enzymatischen Aktivität von Mono-Amin-Oxydase |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US3894914A (cg-RX-API-DMAC10.html) |
| DE (1) | DE2319097C3 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2181376A5 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100501370C (zh) * | 2007-03-19 | 2009-06-17 | 浙江工业大学 | 一种单胺氧化酶活性的荧光检测方法 |
| CN115046990B (zh) * | 2022-04-11 | 2025-05-27 | 东南大学 | 一种定性和定量检测mao-b浓度的方法及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3715325A (en) * | 1970-10-02 | 1973-02-06 | Miles Lab | Insoluble polymeric diazonium salt chromogen |
-
1973
- 1973-04-16 US US351642A patent/US3894914A/en not_active Expired - Lifetime
- 1973-04-16 DE DE2319097A patent/DE2319097C3/de not_active Expired
- 1973-04-18 FR FR7314130A patent/FR2181376A5/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2319097A1 (de) | 1973-11-08 |
| US3894914A (en) | 1975-07-15 |
| FR2181376A5 (cg-RX-API-DMAC10.html) | 1973-11-30 |
| DE2319097B2 (de) | 1975-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69535522T2 (de) | Kupplungsfarbstoff zur spektrophotometrischen Bestimmung von Analyten | |
| DE69108403T2 (de) | Boronsäurekonjugate enthaltende markierungsmittel. | |
| EP0161436B1 (de) | Neue Redox-Indikatoren | |
| DE2920292C3 (de) | L-γ -Glutamyl-3-carboxy-4-hydroxyanilid und dessen Säureadditions- oder Alkalisalze, Verfahren zu deren Herstellung und deren Verwendung zur Bestimmung der Aktivität von γ-Glutamyltranspeptidase | |
| CH623137A5 (cg-RX-API-DMAC10.html) | ||
| EP0167973B1 (de) | Redox-Indikatoren | |
| DE2319097C3 (de) | Verfahren zur Bestimmung der enzymatischen Aktivität von Mono-Amin-Oxydase | |
| DE2223385A1 (de) | Ligandenbestimmung mit enzymen durch rezeptorverdraengung | |
| DE1940045A1 (de) | Heterocyclische Verbindungen | |
| DE69210434T2 (de) | Ein kolorimetrisches Verfahren und Reagenz zum Nachweis von Lithium in einer Testprobe | |
| DE3136508C2 (de) | L-Phenylalanyl-L-argininderivate, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE2147466B2 (de) | 2- BenzothiazoIyl-(2)-3-phenyI-5- (4-N-trimethyl-ammonium-pheyl) tetrazoliumsalze | |
| DE3123520A1 (de) | Gesaettigte aminocyclitderivate, ihre herstellung undsie enthaltende arzneimittel | |
| EP0230985B1 (de) | Neue Gamma-Glutamyl-4-azoanilide, Verfahren zur Herstellung dieser Verbindungen sowie deren Verwendung zur Bestimmung von Gamma-Glutamyltransferase | |
| DE2943582C2 (de) | L-Prolyl-L-phenylalanyl-L-argininderivate, Verfahren zu deren Herstellung und deren Verwendung | |
| DE2646033C3 (de) | L-Leucin-p-aminoanilide, Verfahren zu deren Herstellung und ihre Verwendung zur Messung der Aktivität von Leucylaminopeptidase | |
| DE3889845T2 (de) | Verfahren zur Massanalyse von Wasserstoff-Peroxyd und Reagens dafür. | |
| DE3301470A1 (de) | 4-amino-2,3-disubstituierte-1-(mono- oder-trichlorphenyl)-3-pyrazolin-5-one | |
| DE2115748A1 (en) | Acid phosphatase determination - using alpha naphthylphosphate and diazonium salt | |
| US4179439A (en) | Rifamycins and method for their preparation | |
| DE3939966A1 (de) | Azofarbstoffe und verfahren zur herstellung von (5-amino-2-(2-hydroxyethylamino)phenyl)(2-hydroxyethyl)-sulfon | |
| DE2551952A1 (de) | Neue 1,1-disubstituierte octahydroindolo-chinolizidine | |
| DE69304259T2 (de) | Bestimmungsverfahren für Serumcholinesterase | |
| DE60036584T2 (de) | Ein permanentes fluoreszenz-testverfahren | |
| DE2338932C3 (de) | 9-Substituierte 3-Aminocarbazol-Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Indikator für enzymatische Nachweisreaktionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| E77 | Valid patent as to the heymanns-index 1977 | ||
| 8339 | Ceased/non-payment of the annual fee |